Prevention of chemotherapy induced nausea and vomiting: a focus on aprepitant

By Sankhala Kamalesh K   Pandya Devesh M   Sarantopoulos John   Soefje Scott A   Giles Francis J   Chawla Sant P  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 12, 2009-12 ,pp. : 1607-1614

Informa Healthcare

Access to resources Recommend Favorite

Safety evaluation of aprepitant for the prevention of chemotherapy-induced nausea and vomiting

By Ruhlmann Christina H   Herrstedt Jøørn  

Expert Opinion on Drug Safety, Vol. 10, Iss. 3, 2011-05 ,pp. : 449-462

Informa Healthcare

Access to resources Recommend Favorite

Aprepitant: A Review of its Use in the Prevention of Chemotherapy-Induced Nausea and Vomiting

By Dando T.M.   Perry C.M.  

Drugs, Vol. 64, Iss. 7, 2004-01 ,pp. : 777-794

Adis International

Access to resources Recommend Favorite

Aprepitant plus standard therapy prevents acute and delayed chemotherapy-induced nausea and vomiting

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 12, 2004-12 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Fluorouracil/folinic acid/oxaliplatin: Chemotherapy-induced nausea and vomiting, treated with aprepitant: case report

By  

Reactions Weekly, Vol. 1, Iss. 1342, 2011-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite